FDA Inspection 1032069 — Daniel J. Pallin, MD, MPH
The FDA completed an inspection of Daniel J. Pallin, MD, MPH on Nov 3, 2017 in Boston, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 3, 2017
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Boston, MA (United States)
Additional Details
Clinical Investigator (CI)